TY - JOUR
T1 - Bridged γ-Carbolines and Derivatives Possessing Selective and Combined Affinity for 5-HT2 and D2 Receptors
AU - Mewshaw, Richard E.
AU - Silverman, Lisa S.
AU - Mathew, Rose M.
AU - Kaiser, Carl
AU - Sherrill, Ronald G.
AU - Cheng, Menyan
AU - Tiffany, Carol W.
AU - Karbon, E. William
AU - Bailey, Michael A.
AU - Borosky, Susan A.
AU - Ferkany, John W.
AU - Abreu, Mary E.
PY - 1993/1/1
Y1 - 1993/1/1
N2 - A series of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles and 6,7,8,9,10,11-hexahydro-7,-11-imino-5H-cyclooct[b]indoles was prepared. Structural modifications of the lead compound, 11-[4-(4-fluorobenzoyl)propyl]-5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole (5, Ki = 0.82 nM vs [3H]ketanserin) enabled the identification of the functionality necessary for high affinity at serotonin 5-HT2 and dopamine D2 receptors in ligand binding studies. The indole ring, as well as the benzoyl or isosteric benzisoxazole moiety, were essential for high affinity. Variations of the length of the side chains resulted in ligands having either selective affinity for the 5-HT2 receptor or a combination of 5-HT2 and D2 affinity. In vivo binding studies were performed on selected members in this series. The most potent member, 2-fluoro-11-[4-(4-fluorobenzoyl)butyl]-5,6,7,8,9,-10-hexahydro-7,10-iminocyclohept[b]indole (36) had an ED50 of <1 mg/kg at the 5-HT2 and D2 receptors following oral administration.
AB - A series of 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles and 6,7,8,9,10,11-hexahydro-7,-11-imino-5H-cyclooct[b]indoles was prepared. Structural modifications of the lead compound, 11-[4-(4-fluorobenzoyl)propyl]-5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indole (5, Ki = 0.82 nM vs [3H]ketanserin) enabled the identification of the functionality necessary for high affinity at serotonin 5-HT2 and dopamine D2 receptors in ligand binding studies. The indole ring, as well as the benzoyl or isosteric benzisoxazole moiety, were essential for high affinity. Variations of the length of the side chains resulted in ligands having either selective affinity for the 5-HT2 receptor or a combination of 5-HT2 and D2 affinity. In vivo binding studies were performed on selected members in this series. The most potent member, 2-fluoro-11-[4-(4-fluorobenzoyl)butyl]-5,6,7,8,9,-10-hexahydro-7,10-iminocyclohept[b]indole (36) had an ED50 of <1 mg/kg at the 5-HT2 and D2 receptors following oral administration.
UR - http://www.scopus.com/inward/record.url?scp=0027211949&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027211949&partnerID=8YFLogxK
U2 - 10.1021/jm00062a023
DO - 10.1021/jm00062a023
M3 - Article
C2 - 8496917
AN - SCOPUS:0027211949
SN - 0022-2623
VL - 36
SP - 1488
EP - 1495
JO - Journal of medicinal chemistry
JF - Journal of medicinal chemistry
IS - 10
ER -